ISRCTN72549635已完成未知
Efficacy, tolerability and safety of 0.2% Brimonidine-Tartrate for the treatment of acute non-arteritic anterior ischaemic optic neuropathy (NAION): a 3-month, double-masked, randomised and placebo-controlled trial
Department of Health (UK)0 个研究点目标入组 0 人开始时间: 2003年9月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients with acute non-arteritic anterior ischemic optic neuropathy
排除标准
- •Does not match inclusion criteria
研究者
相似试验
已完成
2 期
Effect of Brimonidine on rosacea diseaseIRCT20161207031288N4Jarfandishan-e Navid-e Salamat (Janus) knowledge-based Company20
进行中（未招募）
1 期
The Efficacy and Safety of Adding the Brinzolamide/Timolol Maleate Fixed Combination (Azarga®) to Prostaglandin Monotherapyprimary open-angle glaucoma ocular hypertension pigment dispersion glaucomaMedDRA version: 9.1 Level: LLT Classification code 10035015 Term: Pigmentary glaucomaMedDRA version: 9.1 Level: LLT Classification code 10030043 Term: Ocular hypertensionMedDRA version: 9.1 Level: LLT Classification code 10036719 Term: Primary open angle glaucomaEUCTR2009-010101-36-DEAlcon Laboratories, Inc.
进行中（未招募）
不适用
Comparison of Safety and Efficacy of Brinzolamide/Timolol Fixed Combination vs COSOPT in Patients with Open-Angle Glaucoma or Ocular Hypertension - Brinzolamide/Timolol Fixed Combination vs COSOPTEUCTR2005-004766-16-BEAlcon Research, Ltd.420
进行中（未招募）
不适用
Comparison of Safety and Efficacy of Brinzolamide/Timolol Fixed Combination vs COSOPT in Patients with Open-Angle Glaucoma or Ocular Hypertension - Brinzolamide/Timolol Fixed Combination vs COSOPTOpen Angle Glaucoma or Ocular HypertensionICD: H40.1/H40.0EUCTR2005-004766-16-SEAlcon Research, Ltd.420
进行中（未招募）
不适用
Comparison of Safety and Efficacy of Brinzolamide/Timolol Fixed Combination vs COSOPT in Patients with Open-Angle Glaucoma or Ocular Hypertension. - Brinzolamide/Timolol Fixed Combination vs COSOPTOpen-Angle Glaucoma or Ocular HypertensionEUCTR2005-004766-16-LTAlcon Research, Ltd.420